Related papers
Related papers
関連論文一覧
Embedded Files
サイエンス株式会社のリニューアルサイトが完成いたしました。
「ヒト膵癌オルガノイド移植マウス」関連
論文
1. Tanaka C, Furihata K, Naganuma S, Ogasawara M, Yoshioka R, Taniguchi H, Furihata M, Taniuchi K. Establishment of a mouse model of pancreatic cancer using human pancreatic cancer cell line S2-013-derived organoid. Hum Cell 35:735-744, 2022. doi: 10.1007/s13577-022-00684-7.
2. 執筆中
「膵癌の血清診断マーカー」関連
論文：
1. Taniuchi K, Tsuboi M, Sakaguchi M, Saibara T. Measurement of serum PODXL concentration for detection of pancreatic cancer. Onco Targets Ther 11:1433-1445, 2018. doi: 10.2147/OTT.S155367.
Measurement of serum PODXL concentration for detection of pancreatic cancer - PubMed (nih.gov)
2. Taniuchi K, Okabayashi T, Sakaguchi M, Iwata J. Measurement of PODXL and SCGB1D2 for detecting intraductal papillary mucinous neoplasm. Nihon Shokakibyo Gakkai Zasshi 118:235-244, 2021. Japanese. doi: 10.11405/nisshoshi.118.235.
「術前化学療法NACバイオマーカー」関連
論文：
1. Taniuchi K, Furihata M, Naganuma S, Sakaguchi M, Saibara T. Overexpression of PODXL/ITGB1 and BCL7B/ITGB1 accurately predicts unfavorable prognosis compared to the TNM staging system in postoperative pancreatic cancer patients. PLoS ONE 14:e0217920, 2019. doi: 10.1371/journal.pone.0217920.
2. Taniuchi K, Ueno M, Yokose T, Sakaguchi M, Yoshioka R, Ogasawara M, Kosaki T, Naganuma S, Furihata M. Upregulation of PODXL and ITGB1 in pancreatic cancer tissues preoperatively obtained by EUS-FNAB correlates with unfavorable prognosis of postoperative pancreatic cancer patients. PLoS ONE 17:e0265172, 2022. doi: 10.1371/journal.pone.0217920.
3. Taniuchi K, Furihata M, Naganuma S, Dabanaka K, Hanazaki K, Saibara T. Podocalyxin-like protein, linked to poor prognosis of pancreatic cancers, promotes cell invasion by binding to gelsolin. Cancer Science 107:1430-1442, 2016. doi: 10.1111/cas.13018.
4. 執筆中
「膵癌の血清診断マーカーRNA」関連
論文：
Kitagawa T, Taniuchi K, Tsuboi M, Sakaguchi M, Kohsaki T, Okabayashi T, Saibara T: Circulating pancreatic cancer exosomal RNAs detect pancreatic cancer. Mol Oncol 13:212-227, 2doi: 10.1002/1878-0261.12398.019.
Circulating pancreatic cancer exosomal RNAs for detection of pancreatic cancer - PubMed (nih.gov)
「膵癌の新しい化学療法レジメン」
論文：
1. Taniuchi K，Yawata T，Tsuboi M, Ueba T，Saibara T. Efficient delivery of small interfering RNAs targeting particular mRNAs into pancreatic cancer cells inhibits invasiveness and metastasis of pancreatic tumors. Oncotarget 10:2869-2886, 2019. doi: 10.18632/oncotarget.26880.
2. Jobu Y, Nishigawa M, Furihata K, Furihata M, Uchida K, Taniuchi K. Inhibitory effects of the combination of rapamycin with gemcitabine plus paclitaxel on the growth of pancreatic cancer tumors. Hum Cell 38:44, 2025. doi: 10.1007/s13577-024-01165-9.
「膵癌に対する創薬：核酸製剤」関連
論文：
1. Taniuchi K, Furihata M, Hanazaki K, Saito M, Saibara T. IGF2BP3-mediated translation in cell protrusions promotes cell invasiveness and metastasis of pancreatic cancer. Oncotarget 5:6832-6845, 2014. doi: 10.18632/oncotarget.2257.
2. Taniuchi K, Furihata M, Saibara T. KIF20A-mediated RNA granule transport system promotes the invasiveness of pancreatic cancer cells. Neoplasia 16:1082-1093, 2014. doi: 10.1016/j.neo.2014.10.007.
3. Taniuchi K，Yawata T，Tsuboi M, Ueba T，Saibara T. Efficient delivery of small interfering RNAs targeting particular mRNAs into pancreatic cancer cells inhibits invasiveness and metastasis of pancreatic tumors. Oncotarget 10:2869-2886, 2019. doi: 10.18632/oncotarget.26880.
4. Taniuchi K, Ogasawara M：KHSRP-bound small nucleolar RNAs associate with promotion of cell invasiveness and metastasis of pancreatic cancer. Oncotarget 11:131-147, 2020. doi: 10.18632/oncotarget.27413.
5. 執筆中
Page updated
Report abuse